Reuters logo
BRIEF-Phase 1/2 clinical trial of Agenus' anti-PD-1 antibody begins
April 20, 2017 / 1:02 PM / 5 months ago

BRIEF-Phase 1/2 clinical trial of Agenus' anti-PD-1 antibody begins

April 20 (Reuters) - Agenus Inc

* Phase 1/2 clinical trial of Agenus’ anti-PD-1 antibody begins

* Agenus Inc - Preliminary safety and efficacy data are expected to be available within next 9-12 months from AGEN2034 study Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below